Aquapheresis therapy, delivered by the Aquadex FlexFlow® System, uses a simplified approach to ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. Compared to renal replacement devices used for ultrafiltration, the Aquadex FlexFlow System is smaller and more portable.
Physicians can specify and adjust the exact amount and rate of fluid to be removed from each patient, resulting in a gradual reduction that has been shown to have no significant clinical impact on blood pressure, heart rate, or the balance of electrolytes (e.g. sodium, potassium, etc.) in the body.1
Up to 500 mL per hour of excess fluid can be removed with no clinically significant impact on electrolyte balance.1,2